HCQ remains the major immunomodulatory agent used to treat systemic lupus erythematosus (SLE), but newer screening techniques have raised concern regarding potential eye toxicity. The 2016 American Academy of Ophthalmology (AAO) Recommendations for Screening for Hydroxychloroquine and Chloroquine Retinopathy recommended a maximum daily HCQ use of 5.0 mg/kg real weight. Medicare allowable ocular testing for chloroquine therapy Chloroquine tablet brand name American College of Rheumatology ACR Summary Hydroxychloroquine Plaquenil®, especially at the higher standard dose of 400 mg per day, independently decreases the risk of cardiovascular. Oct 23, 2018 Hydroxychloroquine HCQ dosing took center stage on October 21 as the focus of the “Great Debate” at the 2018 American College of Rheumatology ACR/Association of Rheumatology Health Professionals ARHP Annual Meeting in Chicago, Illinois. Patient Education Website; Patient Education Newsletter - Current Issue; Patient Education Newsletter Archive; Patient Education Television Channles Dr Rosenbaum is Professor of Ophthalmology, Medicine, and Cell Biology and Chair of the Division of Rheumatology at the Oregon Health & Science University. The AAO also recommends a baseline fundus examination and annual screening after 5 years for patients without major risk factors. Rosenbaum, MD, took the “pro” side of the debate, arguing that the AAO Guidelines are appropriate. Hydroxychloroquine plaquenil american college of rheumatology RA and Hydroxychloroquine How Effective is it for Rheumatoid., The Great Debate at ACR 2018 Hydroxychloroquine Dosing for. Can hydroxychloroquine cause dry eyesCan i take phosphatidylserine while taking plaquenil Duration of Use. After five to seven years of HCQ use, the risk of retinal toxicity is above 1%, and the AAO recommends annual screening. This screening might begin earlier or occur more often in patients at unusual risk because of renal or liver disease slower clearance, old age harder to assess macular changes, underlying retinal disease, and other factors. Hydroxychloroquine Retinopathy Still Alive and Well - Page.. Hydroxychloroquine Plaquenil ACR Patient Education.. Hydroxychloroquine Plaquenil Success, Reviews and Side.. Rheumatology Advisor’s staff will be reporting breaking news associated with research conducted by leading experts in rheumatology. Check back for the latest news from ACR/ARHP 2018. CHICAGO – The 2018 ACR/ARHP Annual Meeting featured a debate that examined whether hydroxychloroquine HCQ dosing should be more than 5 mg/kg in patients with systemic lupus erythematosus SLE. 1 Hydroxychloroquine plaquenil and sulfasalazine azulfidine are used for mild rheumatoid arthritis. they are not as powerful as other dmards, but they usually cause fewer side effects. Adapted from the American College of Rheumatology HYDROXYCHLOROQUINE Generic Name Brand Names Plaquenil WHAT IS IT? Hydroxychloroquine is a DMARD Disease Modifying Anti-Rheumatic Drug used to treat discoid or systemic lupus erythematosus lupus and rheumatoid arthritis RA in patients whose symptoms have not improved with other treatments.